The cell lines used in this study were ranked based on the level of CERS2 expression and mapped to the histology, molecular subtype, genetic instability, and mutational status of classical genes associated with bladder cancer as determined and catalogued in previous studies [23–25] (Figure 5). The gene discussed is CERS2; the disease is urinary bladder cancer.